Strata Critical Medical Inc (SRTA) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket
 


Strata Critical Medical Inc   (NASDAQ: SRTA)


Strata Critical Medical Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Strata Critical Medical Inc 's ROA in the third quarter of 2026?
Strata Critical Medical Inc recorded a cumulative net loss of $-25 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -7.47%.

However, within the Healthcare sector 274 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 351, from total ROA ranking in the second quarter of 2026 at 430.

What is ROA?



Return On Assets (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 0.48 % 31.21 % 30.76 % 22.1 % 127.78 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -25 40 47 41 40
Return On Assets (TTM) -7.47 % 12.13 % 15.09 % 14.15 % 14.55 %
SRTA's Total Ranking # 351 # 430 # 361 # 3180 # 3333
Total Assets (TTM) in million 337 338 328 325 335
Seq. Total Assets Change -0.51 % 3.29 % 0.66 % -2.87 % 29.92 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 87
Sector # 275
Overall # 3082

Return On Assets Statistics
High Average Low
15.09 %
-6.56 %
-18.21 %
(Mar 31 2026)   (Jun 30 2023)





Financial Statements
Strata Critical Medical Inc 's Assets $ 337 million SRTA's Balance sheet
Strata Critical Medical Inc 's Income $ -8 million Quarterly SRTA's Income Statement
SRTA's Income by Division See SRTA's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Sep 30 2021)
FY 2021
Y / Y Total Assets Change 30 % -8.31 % -11.63 % -10.02 % 23.59 %
Total Assets in million 325 250 273 309 343
Y / Y Net Income Change - - - - -
Net Income in million 41 -27 -56 -27 -40
Annual Return On Assets 12.7 % -10.91 % -20.54 % -8.82 % -11.66 %




Comment on SRTA's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 12.7 % compared to prior year, due to annual net income growth of % to $41.35 million, while value of Strata Critical Medical Inc 's overall assets grew just by 30 % to $325.47 million, compared to $325.47 a year before.


More Return On Assets Ratios
SRTA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SRTA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SRTA's Competitors
Subscribers only: Roa for Strata Critical Medical Inc 's Suppliers
Subscribers only: Return On Assets for SRTA's Customers

You may also want to know
SRTA's Roi SRTA's Inventory Turnover Ratio SRTA's Growth Rates SRTA's Dividend Comparisons
SRTA's Profitability Ratios SRTA's Asset Turnover Ratio SRTA's Dividend Growth
SRTA's Roe SRTA's Valuation Ratios SRTA's Financial Strength Ratios SRTA's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA


Date modified: 2026-11-04T15:26:21+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.